Trial
NCT00988052
A Study To Evaluate the Long-Term Safety, Tolerability and Effect on Disease Course
Phase IIITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Teva Branded Pharmaceutical Products R&D, Inc.
Collaborators
—
Condition
Relapsing Multiple Sclerosis
Intervention
Laquinimod
Why stopped
Sponsor terminated RRMS studies as sufficient long term clinical data was collected for the study drug in the relevant dose.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-12-09